NO20013478L - Nye aralkylaminer av spirofuropyridiner som er nyttige i terapi - Google Patents

Nye aralkylaminer av spirofuropyridiner som er nyttige i terapi

Info

Publication number: NO20013478L
Authority: NO; Norway
Prior art keywords: spirofuropyridines; aralkylamines; therapy; useful; new
Prior art date: 1999-01-15

Application number

NO20013478A

Other languages

English (en)

Norwegian (no)

Other versions

NO20013478D0 (no

Inventor

Iii James Loch

George Mullen

Eifion Phillips

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-01-15

Filing date

2001-07-13

Publication date

2001-09-14

2001-07-13 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2001-07-13 Publication of NO20013478D0 publication Critical patent/NO20013478D0/no

2001-09-14 Publication of NO20013478L publication Critical patent/NO20013478L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

NO20013478A 1999-01-15 2001-07-13 Nye aralkylaminer av spirofuropyridiner som er nyttige i terapi NO20013478L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9900100A SE9900100D0 (sv)	1999-01-15	1999-01-15	New compounds
PCT/SE1999/002478 WO2000042044A1 (fr)	1999-01-15	1999-12-23	Nouvelles aralkylamines de spirofuropyridines utiles en therapie

Publications (2)

Publication Number	Publication Date
NO20013478D0 NO20013478D0 (no)	2001-07-13
NO20013478L true NO20013478L (no)	2001-09-14

Family

ID=20414101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20013478A NO20013478L (no)	1999-01-15	2001-07-13	Nye aralkylaminer av spirofuropyridiner som er nyttige i terapi

Country Status (34)

Country	Link
US (2)	US6995167B2 (fr)
EP (1)	EP1147114B1 (fr)
JP (1)	JP2002534525A (fr)
KR (1)	KR100660496B1 (fr)
CN (1)	CN1132837C (fr)
AR (1)	AR022283A1 (fr)
AT (1)	ATE240960T1 (fr)
AU (1)	AU775433B2 (fr)
BR (1)	BR9916906A (fr)
CA (1)	CA2359990A1 (fr)
CZ (1)	CZ20012554A3 (fr)
DE (1)	DE69908185T2 (fr)
DK (1)	DK1147114T3 (fr)
EE (1)	EE04528B1 (fr)
ES (1)	ES2200590T3 (fr)
HK (1)	HK1040517B (fr)
HU (1)	HUP0200513A3 (fr)
ID (1)	ID30034A (fr)
IL (1)	IL144266A0 (fr)
IS (1)	IS6000A (fr)
MY (1)	MY118109A (fr)
NO (1)	NO20013478L (fr)
NZ (1)	NZ512733A (fr)
PT (1)	PT1147114E (fr)
RU (1)	RU2233282C2 (fr)
SA (1)	SA00200987B1 (fr)
SE (1)	SE9900100D0 (fr)
SI (1)	SI1147114T1 (fr)
SK (1)	SK9932001A3 (fr)
TR (1)	TR200102042T2 (fr)
TW (2)	TW200413387A (fr)
UA (1)	UA71598C2 (fr)
WO (1)	WO2000042044A1 (fr)
ZA (1)	ZA200105527B (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9900100D0 (sv)	1999-01-15	1999-01-15	Astra Ab	New compounds
FR2790474B1 (fr) *	1999-03-05	2001-04-06	Synthelabo	Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
ATE353332T1 (de) *	2001-06-01	2007-02-15	Astrazeneca Ab	Neuer, für die therapie geeigneter ligand für nikotinische acetylcholinrezeptoren
US6569865B2 (en)	2001-06-01	2003-05-27	Astrazeneca Ab	Spiro 1-azabicyclo[2.2.2]octane-3,2′(3′h)-furo[2,3-b]pyridine
PL369895A1 (en)	2001-10-02	2005-05-02	Pharmacia & Upjohn Company	Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
KR20040099446A (ko) *	2002-04-18	2004-11-26	아스트라제네카 아베	헤테로시클릭 화합물
BR0309342A (pt) *	2002-04-18	2005-02-15	Astrazeneca Ab	Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
JP4511195B2 (ja) *	2002-04-18	2010-07-28	アストラゼネカ・アクチエボラーグ	フリル化合物
EP2298759A1 (fr)	2002-08-30	2011-03-23	Memory Pharmaceuticals Corporation	Dérivés d'anabaseine utiles pour le traitement de maladies neurodégénératives
SE0202598D0 (sv) *	2002-09-02	2002-09-02	Astrazeneca Ab	Alpha-7 Nicotinic receptor agonists and statins in combination
GB0220581D0 (en)	2002-09-04	2002-10-09	Novartis Ag	Organic Compound
BR0314485A (pt)	2002-09-25	2005-07-26	Memory Pharm Corp	Indazóis, benzotiazóis e benzoisotiazóis, composto, composição farmacêutica, método desativação/estimulação seletiva de receptores nicotìnicos de a-7 em um mamìfero e método de tratamento e/ou prevenção de uma doença com os mesmos
ATE378048T1 (de) *	2002-12-06	2007-11-15	The Feinstein Inst Medical Res	Hemmung von entzündungen unter verwendungvon alpha-7-rezeptor verbindenden cholinergen agonisten
US7238715B2 (en) *	2002-12-06	2007-07-03	The Feinstein Institute For Medical Research	Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
WO2004063201A1 (fr) *	2003-01-08	2004-07-29	Mitsubishi Pharma Corporation	Agent therapeutique pour la scizophrenie
WO2005000250A2 (fr) *	2003-06-24	2005-01-06	Johns Hopkins University	Agents d'imagerie et procedes d'imagerie du recepteur cholinergique nicotinique alpha 7
NZ546413A (en) *	2003-10-21	2009-12-24	Astrazeneca Ab	Spirofuropyridine aryl ligands for nicotinic acetylcholine receptors and their use in therapy
US7045530B2 (en)	2003-12-22	2006-05-16	Abbott Laboratories	Spirocyclic quinuclidinic ether derivatives
BRPI0508771A (pt)	2004-03-25	2007-08-14	Memory Pharm Corp	indazóis, benzotiazóis, benzoisotiazóis, benzisoxazóis, e a preparação e usos dos mesmos
PE20060437A1 (es)	2004-06-18	2006-06-08	Novartis Ag	COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en)	2004-07-14	2004-08-18	Novartis Ag	Organic compounds
MY145694A (en) *	2005-04-11	2012-03-30	Xenon Pharmaceuticals Inc	Spiroheterocyclic compounds and their uses as therapeutic agents
GB0521508D0 (en)	2005-10-21	2005-11-30	Novartis Ag	Organic compounds
US8316104B2 (en)	2005-11-15	2012-11-20	California Institute Of Technology	Method and apparatus for collaborative system
GB0525672D0 (en)	2005-12-16	2006-01-25	Novartis Ag	Organic compounds
GB0525673D0 (en)	2005-12-16	2006-01-25	Novartis Ag	Organic compounds
RU2448111C2 (ru) *	2006-08-21	2012-04-20	Дженентек, Инк.	Соединения азабензофуранила и способ их применения
TW200901974A (en)	2007-01-16	2009-01-16	Wyeth Corp	Compounds, compositions, and methods of making and using them
SA08290475B1 (ar) *	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
MY157518A (en)	2008-06-20	2016-06-15	Astrazeneca Ab	Dibenzothiazepine derivatives and use thereof
US8263606B2 (en)	2008-10-17	2012-09-11	Xenon Pharmaceuticals Inc.	Spiro-oxindole compounds and their use as therapeutic agents
KR20140146216A (ko)	2008-11-19	2014-12-24	포럼 파마슈티칼즈 인크.	(ｒ)-７-클로로-ｎ-(퀴누클리딘-３-일)벤조［ｂ］티오펜-２-카르복사미드 및 그 약학적으로 허용가능한 염을 이용한 인지 장애의 치료
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
MX2011011972A (es) *	2009-05-11	2011-12-08	Envivo Pharmaceuticals Inc	Tratamiento de trastornos cognitivos con determinados receptores de acido nicotinico alfa-7 en combinacion con inhibidores de acetilcolinesterasa.
AR077252A1 (es)	2009-06-29	2011-08-10	Xenon Pharmaceuticals Inc	Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
MY165579A (en)	2009-10-14	2018-04-05	Xenon Pharmaceuticals Inc	Synthetic methods for spiro-oxindole compounds
WO2011106729A2 (fr)	2010-02-26	2011-09-01	Xenon Pharmaceuticals Inc.	Compositions pharmaceutiques de composé spiro-oxindole pour administration topique et leur utilisation en tant qu'agents thérapeutiques.
PL3029039T3 (pl)	2010-05-17	2018-04-30	Forum Pharmaceuticals Inc.	Formulacje farmaceutyczne zawierające postacie krystaliczne jednowodnego chlorowodorku (R)-7-chloro-N-(chinuklidyn-3-ylo)benzo[b]tiofeno-2-karboksyamidu
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
KR20150002794A (ko)	2012-04-12	2015-01-07	제논 파마슈티칼스 인크.	치료제로서 유용한 스파이로-옥시인돌 화합물을 위한 비대칭적 합성
HK1208356A1 (en)	2012-05-08	2016-03-04	Forum Pharmaceuticals Inc.	Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
WO2014122474A1 (fr)	2013-02-07	2014-08-14	Takeda Pharmaceutical Company Limited	Carboxylates de pipéridin-1-yle et d'azépin-1-yle à titre d'agonistes du récepteur muscarinique m4
EP3010900B1 (fr)	2013-06-21	2018-01-03	Takeda Pharmaceutical Company Limited	Derive de 1-sulfonylpiperidine comme des modulateurs des recepteurs prokineticin
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
US9682033B2 (en)	2015-02-05	2017-06-20	Teva Pharmaceuticals International Gmbh	Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compound
WO2017218920A1 (fr)	2016-06-16	2017-12-21	Teva Pharmaceuticals International Gmbh	Synthèse asymétrique de funapide
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0311313B1 (fr) *	1987-10-05	1995-05-10	Yamanouchi Pharmaceutical Co. Ltd.	Composés spiro hétérocycliques et leur préparation
JPH0195922A (ja)	1987-10-08	1989-04-14	Mazda Motor Corp	車両のサスペンション制御装置
SU1540240A1 (ru) *	1988-05-16	1995-09-10	Институт Тонкой Органической Химии Им.А.Л.Мнджояна	5-ЗАМЕЩЕННЫЕ 1-АМИНО -8,9-ДИГИДРО -8,8-ДИМЕТИЛ-3, 6Н- ПИРАЗОЛО [3,4-B] ПИРАНО[[4′,3′-d]] ПИРИДИНА ИЛИ ИХ ГИДРОХЛОРИДЫ, ОБЛАДАЮЩИЕ ПРОТИВОСУДОРОЖНОЙ АКТИВНОСТЬЮ
ES2145922T3 (es) *	1994-08-24	2000-07-16	Astrazeneca Ab	Compuestos espiro-azabiciclicos utiles en terapia.
PT842178E (pt)	1995-07-28	2001-08-30	Abbott Lab	Furopiridina tienopiridina pirrolopiridina e compostos relacionados de pirimidina piridazina e triazina uteis no controlo da transmissao sinaptica quimica
US6156783A (en) *	1996-04-30	2000-12-05	Smithkline Beecham P.L.C.	Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use
AR013184A1 (es) *	1997-07-18	2000-12-13	Astrazeneca Ab	Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
SE9900100D0 (sv)	1999-01-15	1999-01-15	Astra Ab	New compounds

1999
- 1999-01-15 SE SE9900100A patent/SE9900100D0/xx unknown
- 1999-12-23 RU RU2001122812/04A patent/RU2233282C2/ru not_active IP Right Cessation
- 1999-12-23 CA CA002359990A patent/CA2359990A1/fr not_active Abandoned
- 1999-12-23 CN CN998164224A patent/CN1132837C/zh not_active Expired - Fee Related
- 1999-12-23 SK SK993-2001A patent/SK9932001A3/sk unknown
- 1999-12-23 HK HK02102161.7A patent/HK1040517B/en not_active IP Right Cessation
- 1999-12-23 SI SI9930375T patent/SI1147114T1/xx unknown
- 1999-12-23 WO PCT/SE1999/002478 patent/WO2000042044A1/fr not_active Ceased
- 1999-12-23 DK DK99967044T patent/DK1147114T3/da active
- 1999-12-23 EP EP99967044A patent/EP1147114B1/fr not_active Expired - Lifetime
- 1999-12-23 UA UA2001085777A patent/UA71598C2/uk unknown
- 1999-12-23 DE DE69908185T patent/DE69908185T2/de not_active Expired - Fee Related
- 1999-12-23 US US09/529,654 patent/US6995167B2/en not_active Expired - Fee Related
- 1999-12-23 HU HU0200513A patent/HUP0200513A3/hu unknown
- 1999-12-23 BR BR9916906-1A patent/BR9916906A/pt not_active Application Discontinuation
- 1999-12-23 ES ES99967044T patent/ES2200590T3/es not_active Expired - Lifetime
- 1999-12-23 AU AU23343/00A patent/AU775433B2/en not_active Ceased
- 1999-12-23 TR TR2001/02042T patent/TR200102042T2/xx unknown
- 1999-12-23 NZ NZ512733A patent/NZ512733A/en unknown
- 1999-12-23 CZ CZ20012554A patent/CZ20012554A3/cs unknown
- 1999-12-23 ID IDW00200101529A patent/ID30034A/id unknown
- 1999-12-23 AT AT99967044T patent/ATE240960T1/de not_active IP Right Cessation
- 1999-12-23 IL IL14426699A patent/IL144266A0/xx unknown
- 1999-12-23 EE EEP200100370A patent/EE04528B1/xx not_active IP Right Cessation
- 1999-12-23 PT PT99967044T patent/PT1147114E/pt unknown
- 1999-12-23 KR KR1020017008939A patent/KR100660496B1/ko not_active Expired - Fee Related
- 1999-12-23 JP JP2000593611A patent/JP2002534525A/ja active Pending
2000
- 2000-01-13 AR ARP000100156A patent/AR022283A1/es not_active Application Discontinuation
- 2000-01-13 MY MYPI20000100A patent/MY118109A/en unknown
- 2000-01-21 TW TW093106537A patent/TW200413387A/zh unknown
- 2000-01-21 TW TW089100989A patent/TWI227237B/zh not_active IP Right Cessation
- 2000-02-21 SA SA00200987A patent/SA00200987B1/ar unknown
2001
- 2001-07-04 ZA ZA200105527A patent/ZA200105527B/en unknown
- 2001-07-12 IS IS6000A patent/IS6000A/is unknown
- 2001-07-13 NO NO20013478A patent/NO20013478L/no not_active Application Discontinuation
2005
- 2005-07-14 US US11/181,098 patent/US7196096B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20050250802A1 (en)	2005-11-10
TR200102042T2 (tr)	2002-05-21
MY118109A (en)	2004-08-30
EP1147114A1 (fr)	2001-10-24
HK1040517B (en)	2003-09-05
AU2334300A (en)	2000-08-01
PT1147114E (pt)	2003-10-31
ATE240960T1 (de)	2003-06-15
IL144266A0 (en)	2002-05-23
CA2359990A1 (fr)	2000-07-20
KR100660496B1 (ko)	2006-12-22
EP1147114B1 (fr)	2003-05-21
US7196096B2 (en)	2007-03-27
BR9916906A (pt)	2001-10-30
AU775433B2 (en)	2004-07-29
EE200100370A (et)	2002-10-15
NO20013478D0 (no)	2001-07-13
CZ20012554A3 (cs)	2002-01-16
WO2000042044A1 (fr)	2000-07-20
SE9900100D0 (sv)	1999-01-15
JP2002534525A (ja)	2002-10-15
ID30034A (id)	2001-11-01
HUP0200513A2 (en)	2002-06-29
EE04528B1 (et)	2005-08-15
DK1147114T3 (da)	2003-09-15
IS6000A (is)	2001-07-12
US20030149065A1 (en)	2003-08-07
TW200413387A (en)	2004-08-01
ES2200590T3 (es)	2004-03-01
ZA200105527B (en)	2002-10-04
CN1132837C (zh)	2003-12-31
TWI227237B (en)	2005-02-01
SI1147114T1 (en)	2003-12-31
HK1040517A1 (en)	2002-06-14
US6995167B2 (en)	2006-02-07
SK9932001A3 (en)	2002-04-04
RU2233282C2 (ru)	2004-07-27
DE69908185T2 (de)	2004-06-03
SA00200987B1 (ar)	2006-11-07
KR20010086167A (ko)	2001-09-08
UA71598C2 (en)	2004-12-15
NZ512733A (en)	2003-08-29
AR022283A1 (es)	2002-09-04
CN1337964A (zh)	2002-02-27
HUP0200513A3 (en)	2004-07-28
DE69908185D1 (de)	2003-06-26

Publication	Publication Date	Title
NO20013478D0 (no)	2001-07-13	Nye aralkylaminer av spirofluorpyridiner som er nyttige i terapi
NO20014960L (no)	2001-12-10	Nye fremgangsmåter for behandling
NO20014950D0 (no)	2001-10-11	Nye behandlingsmetoder
NO20021400D0 (no)	2002-03-20	Terapeutiske konazolinderivater
NO20021811D0 (no)	2002-04-17	Nye oksabispidinforbindelser som er nyttige i behandlingen av hjertearrytmier
EE04190B1 (et)	2003-12-15	Asendatud bensopüraani derivaatide kasutamine põletiku raviks
NO20002958D0 (no)	2000-06-09	Benzamidinderivater som koagulasjonsfaktor Xa-hemmere
FI20000677A0 (fi)	2000-03-23	Oksiimijohdannaiset ja niiden käyttö latentteina happoina
SE0001090D0 (sv)	2000-03-28	Oximderivat och deras användning som latenta syror
IS5760A (is)	2000-12-08	Meðferðarlegar bíarýl afleiður
FI20000863A0 (fi)	2000-04-11	Uusi hoitomenetelmä
NO20022600L (no)	2002-08-05	Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme
DE60025536D1 (de)	2006-04-06	Beschichtung von tablettenkernen
NO20020810L (no)	2002-02-19	Nye fenylpiperaziner
DK1237857T3 (da)	2004-09-20	Nye Phenalkyloxyphenylderivater
NO20015738D0 (no)	2001-11-26	Terapeutisk bruk av melatonin
EE200100381A (et)	2002-12-16	Morfolinobensamiidi uued soolad
NO20015033D0 (no)	2001-10-16	Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner
NO20024504L (no)	2002-11-22	Nye imidazolderivater med anti-inflammatorisk aktivitet
NO20014845D0 (no)	2001-10-05	Anvendelse av arylalkanoylpyridaziner
NO20016127D0 (no)	2001-12-14	Nye bispidinforbindelser som er nyttige i behandlingen av hjertearytmier
NO20016117D0 (no)	2001-12-14	Nye bispidinforbindelser som er nyttige i behandlingen av hjertearytmier
NO20014149D0 (no)	2001-08-27	Nye dipeptidforbindelser og deres anvendelse som medisiner
NO20016120D0 (no)	2001-12-14	Nye bispidinforbindelser som er nyttige i behandlingen av hjertearytmier
NO20016119D0 (no)	2001-12-14	Nye bispidinforbindelser som er nyttige i behandlingen av hjertearytmier

Legal Events

Date	Code	Title	Description
2009-06-15	FC2A	Withdrawal, rejection or dismissal of laid open patent application